Literature DB >> 9397656

Onychomycosis. Baseline results of an observational study.

J R Schein1, D Gause, D M Stier, D P Lubeck, M M Bates, R Fisk.   

Abstract

The investigators present an analysis of baseline quality-of-life and patient-management approaches from an observational study of 150 patients being treated by podiatric physicians and dermatologists for onychomycosis. The majority (73%) made the initial office visit specifically because of their onychomycosis. Both men and women indicated that they had substantial physical discomfort as well as concerns related to appearance. Women reported significantly more problems than did men as a result of their onychomycosis. Physicians reported that 54% of patients suffered from toenail discomfort, 36% had pain while walking, 40% reported that their condition limited wearing of shoes, and 67% were embarrassed by the condition. The results of this study suggest that the treatment approach of podiatric physicians is more likely to address the palliative concerns of patients with onychomycosis, while the approach of dermatologists is more likely to attempt a definitive cure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397656     DOI: 10.7547/87507315-87-11-512

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  15 in total

1.  A health-related quality of life measure for use in patients with onychomycosis: a validation study.

Authors:  D P Lubeck; D Gause; J R Schein; L E Prebil; L P Potter
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Cost of treatment for onychomycosis. Data from a 9-month observational study.

Authors:  D M Stier; C Henke; J Schein; J Doyle; W H Schonfeld; J Broering
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence.

Authors:  Antonella Tosti; Boni E Elewski
Journal:  Skin Appendage Disord       Date:  2016-09-14

Review 4.  Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

Authors:  V N Joish; E P Armstrong
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 5.  Patient-Reported Outcomes in Onychomycosis: A Review of Psychometrically Evaluated Instruments in Assessing Treatment Effectiveness.

Authors:  Jenny Wang; Lauren E Wiznia; Evan A Rieder
Journal:  Skin Appendage Disord       Date:  2017-04-21

6.  Penetration of ((14)C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish.

Authors:  Joshua A Zeichner; Linda Stein Gold; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

Review 7.  Onychomycosis: health-related quality of life considerations.

Authors:  James W Shaw; Vijay N Joish; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life.

Authors:  Antonella Tosti; Bom E Elewski
Journal:  J Clin Aesthet Dermatol       Date:  2014-11

Review 9.  Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical Therapy.

Authors:  Boni E Elewski; Antonella Tosti
Journal:  J Clin Aesthet Dermatol       Date:  2015-11

10.  Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.